$209.17
-0.84-0.40%
At close: -
$209.25
0.080.04%
After Hours: 5:44 PM EDT
Comments
Loading...
Latest AbbVie Stock News | NYSE:ABBV | Benzinga
Get the latest news on AbbVie stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on AbbVie performance
Categories: All
Monday, March 24, 2025
Friday, March 21, 2025
Thursday, March 20, 2025
Monday, March 17, 2025
Tuesday, March 11, 2025
Friday, March 07, 2025
Wednesday, March 05, 2025
Tuesday, March 04, 2025
Monday, March 03, 2025
Friday, February 28, 2025
Thursday, February 27, 2025
Monday, February 24, 2025
Tuesday, February 18, 2025
Monday, February 17, 2025
Friday, February 14, 2025
Wednesday, February 12, 2025
Friday, February 07, 2025
Wednesday, February 05, 2025
Monday, February 03, 2025
- Citigroup Maintains Buy on AbbVie, Raises Pri...
- Looking At AbbVie's Recent Unusual Options Activity
- Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
- Truist Securities Maintains Buy on AbbVie, Ra...
- UBS Maintains Neutral on AbbVie, Raises Price...
- Wells Fargo Maintains Overweight on AbbVie, R...
- AbbVie shares are trading higher after multip...
- Morgan Stanley Maintains Overweight on AbbVie...
- Raymond James Reiterates Outperform on AbbVie...
- Guggenheim Maintains Buy on AbbVie, Raises Pr...
- BMO Capital Maintains Outperform on AbbVie, R...
Friday, January 31, 2025
- Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
- Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday?
- Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday
- AbbVie Exec Sees An Unfavorable Impact Of 4% ...
- AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline
- AbbVie Expects Net Revenues Of About $12.8B F...
- AbbVie Exec Says Co Expects Humira Revenue Of...
- AbbVie Exec Says Co Anticipates Humira Access...
- AbbVie Exec Says Skyrizi And Rinvoq Are Expec...
- CORRECTION: AbbVie Sees FY25 Adj. EPS $12.12-...
- AbbVie shares are trading higher following be...